Biotech

All Articles

A more detailed check out Intense Biotech's Fierce 15

.In this particular week's incident of "The Top Line," we are actually diving right into Strong Biot...

Lilly experiences period 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's party celebrating the approval of Alzheimer's ...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Lykos will definitely inquire FDA to reevaluate its own selection observing denial of MDMA therapy for trauma

.Adhering to a poor showing for Lykos Therapeutics' MDMA applicant for trauma at a latest FDA consul...

AN 2 fifty percents head count, quits phase 3 test after data disappoint

.AN2 Rehabs is reviewing its service in action to uninspired midphase information, promising to lay ...

Merck spends $700M for bispecific, snooping autoimmune position as well as possibility to test Amgen in cancer cells

.Merck &amp Co. is paying out $700 million in advance to challenge Amgen in a blood stream cancer ma...

Gilead pays J&ampJ $320M to go out licensing offer for seladelpar

.With Gilead Sciences about to an FDA decision for its liver illness medication seladelpar, the firm...

' All palms on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks can view the firms setting up outdoors tents at basecamp behind...

Entero giving up staff, abandoning workplace and also pausing R&ampD

.Mattress Liquidators has turned Entero Rehabs white as a sheet. The creditor purchased Entero to re...

Exelixis falls ADC after deciding it is actually no match for Tivdak

.Exelixis is actually giving up on its tissue variable (TF)- targeting antibody-drug conjugate after...